Yaccarino’s Break From Musk Was Months in the Making
As chief executive of Elon Musk’s X, Linda Yaccarino navigated two turbulent years of charm offensives and legal threats to stabilize a bruised business-just in time for Musk’s merger of X with xAI.
—-
How Volkswagen’s Electric Bus Went From American Flagship to Flop
The German company’s hyped reboot of its iconic vintage van has been stunted by a luxury price tag, Trump’s trade war and an embarrassing recall.
—-
Tesla Shareholders Press Board to Schedule Annual Meeting
Under Texas law, companies are required to hold annual meetings every 13 months.
—-
Ford, GM Earnings Are Coming. Uncertainty Is Still Ridiculously High.
GM reports second quarter earnings July 22. Tesla reports second quarter earnings July 23. Ford reports second quarter earnings July 30.
—-
Amazon’s Prime Day Starts Strong but the Game Is Long
U.S. retailers drove nearly $8 billion in online sales on Tuesday-the biggest e-commerce day so far in 2025. Prime Day has expanded to four days.
—-
Delta’s Earnings Land Thursday. It Looks Like a ‘Lost Year’ for Airline Stocks.
The carrier will report earnings Thursday, providing an update on the health of the travel sector and the U.S. economy.
—-
Ferrero Nears Deal to Acquire Maker of Froot Loops, Frosted Flakes Cereals
A deal for cereal maker WK Kellogg could be finalized as soon as this week.
—-
How Nvidia Became the World’s First $4 Trillion Company
The chip maker at the beating heart of the AI boom is embedded in gaming, data centers and crypto mining.
—-
Stadium Developer CEO Charged With Bid-Rigging Over New Texas Arena
Timothy Leiweke was indicted over allegations that he convinced a rival firm not to compete on the project.
—-
Angeles Equity Partners and Kain Capital Merge Occupational Health Companies
Each private-equity firm will own half of the new combined company, which mainly operates in California.
—-
Merck to Buy Verona Pharma in $10 Billion Deal
The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.
—-
Prosecutors Question Doctors About UnitedHealth’s Medicare Billing Practices
Justice Department prosecutors recently interviewed former employees about company practices that boost federal payments.
(END) Dow Jones Newswires
July 09, 2025 23:15 ET (03:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.